Close Menu

NEW YORK (360Dx) — SQI Diagnostics said today that it is planning a non-brokered private placement of stock and warrants for gross proceeds of up to C$2.5 million ($1.9 million).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.